SAFE Banking Act May Likely Pass Ahead of Midterms
The SAFE Banking Act, aka cannabis-friendly financial legislation in the US, will be passed before November’s midterm elections.
That was the view of Jeff Schultz, partner at cannabis-focused New York law firm Feuerstein Kulick, at a Jefferies Cannabis Summit, meaning that cannabis companies be given access to banking services that have been denied even in states where the substance has been legalised for recreational or medical use.
With Joe Biden’s Democrats in “desperate need” of a win, the Secure and Fair Enforcement (SAFE) banking act is “low hanging bipartisan fruit” that they can claim victory and forward progress to voters.
Other, more comprehensive bills, such as from Senate Majority Leader Chuck Schumer’s and Representative Nancy Mace, stand very little chance of being passed, Schultz said, especially.
As neither Republicans nor Democrats will let the other party champion federal cannabis legalization, Schultz said a bipartisan approach was likely to be necessary for a more comprehensive piece of cannabis legislation to be passed and enacted.
This was one of the “key takeaways” for Jefferies analysts at the conference, with others being on the M&A outlook in what has been a depressed equity market for the sector.
Distressed assets, including attractive brands, are available to those looking for acquisitions, with those well-capitalized and disciplined operators who were able to raise money in 2021 best-positioned for M&A opportunities.
M&A strategies have “not necessarily changed in this challenging environment where equity multiples by and large are depressed, but there is a greater emphasis on the need to stay patient”.
“This low valuation environment has also changed the way targets look at M&A, with a greater emphasis on performing diligence on the acquirer just as intensely as an acquirer typically performs diligence a target.”
With the cost to build a new facility far higher now than even a few months ago, given inflation, rising rates and supply chain costs, it was said that it is therefore preferable to “buy” rather than “build” cultivation facility investments at this stage — “and capital providers would be unlikely to underwrite facilities that are not already built”.
SAFE Banking Act May Likely Pass Ahead of Midterms
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
